{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:20:46Z","timestamp":1790522446124,"version":"4.1.0"},"reference-count":51,"publisher":"BMJ","issue":"7","funder":[{"name":"CIHR\/DSEN New Investigator Award in Knowledge Synthesis"},{"name":"Tier 1 Canada Research Chair in Knowledge Translation"},{"name":"Tier 2 Canada Research Chair in Knowledge Synthesis"},{"name":"Canadian Institutes for Health Research\/Drug Safety and Effectiveness Network"},{"name":"Banting Postdoctoral Fellowship Program from the CIHR"},{"DOI":"10.13039\/501100003179","name":"Alberta Heritage Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,6,2]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Compare the safety of antiepileptic drugs (AEDs) on neurodevelopment of infants\/children exposed in utero or during breast feeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>Systematic review and Bayesian random-effects network meta-analysis (NMA). MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were searched until 27 April 2017. Screening, data abstraction and quality appraisal were completed in duplicate by independent reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>29 cohort studies including 5100 infants\/children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Monotherapy and polytherapy AEDs including first-generation (carbamazepine, clobazam, clonazepam, ethosuximide, phenobarbital, phenytoin, primidone, valproate) and newer-generation (gabapentin, lamotrigine, levetiracetam, oxcarbazepine, topiramate, vigabatrin) AEDs. Epileptic women who did not receive AEDs during pregnancy or breast feeding served as the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Cognitive developmental delay and autism\/dyspraxia were primary outcomes. Attention-deficit hyperactivity disorder, language delay, neonatal seizures, psychomotor developmental delay and social impairment were secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The NMA on cognitive developmental delay (11 cohort studies, 933 children, 18 treatments) suggested that among all AEDs only valproate was statistically significantly associated with more children experiencing cognitive developmental delay compared with control (OR=7.40, 95% credible interval (CrI) 3.00 to 18.46). The NMA on autism (5 cohort studies, 2551 children, 12 treatments) suggested that oxcarbazepine (OR 13.51, CrI 1.28 to 221.40), valproate (OR 17.29, 95% CrI 2.40 to 217.60), lamotrigine (OR 8.88, CrI 1.28 to 112.00) and lamotrigine+valproate (OR 132.70, CrI 7.41 to 3851.00) were associated with significantly greater odds of developing autism compared with control. The NMA on psychomotor developmental delay (11 cohort studies, 1145 children, 18 treatments) found that valproate (OR 4.16, CrI 2.04 to 8.75) and carbamazepine+phenobarbital+valproate (OR 19.12, CrI 1.49 to 337.50) were associated with significantly greater odds of psychomotor delay compared with control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Valproate alone or combined with another AED is associated with the greatest odds of adverse neurodevelopmental outcomes compared with control. Oxcarbazepine and lamotrigine were associated with increased occurrence of autism. Counselling is advised for women considering pregnancy to tailor the safest regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>PROSPERO database (CRD42014008925).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-017248","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T20:40:28Z","timestamp":1500583228000},"page":"e017248","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":194,"title":["Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"7","author":[{"given":"Areti Angeliki","family":"Veroniki","sequence":"first","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rios","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Cogo","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E","family":"Straus","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"},{"name":"Department of Medicine, University of Toronto, 27 King\u2019s College Circle, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children,555 University Avenue, Toronto, Canada"},{"name":"Department of Paediatrics, University of Toronto, Toronto, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Medical Sciences Building, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Kealey","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Reynen","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Soobiah","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"},{"name":"Institute for Health Policy Management & Evaluation,University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kednapa","family":"Thavorn","sequence":"additional","affiliation":[{"name":"School of Epidemiology,Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada"},{"name":"Clinical Epidemiology Program,Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada"},{"name":"Institute of Clinical and Evaluative Sciences (ICES uOttawa), Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[{"name":"School of Epidemiology,Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada"},{"name":"Ottawa Hospital Research Institute,Center for Practice Changing Research, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda R","family":"Hemmelgarn","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Yazdi","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"D'Souza","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C","family":"Tricco","sequence":"additional","affiliation":[{"name":"Li Ka Shing Knowledge Institute,St. Michael\u2019s Hospital, Toronto, Canada"},{"name":"Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"2025121603330149000_7.7.e017248.1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord"},{"key":"2025121603330149000_7.7.e017248.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02130.x"},{"key":"2025121603330149000_7.7.e017248.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01480.x"},{"key":"2025121603330149000_7.7.e017248.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2008.04.022"},{"key":"2025121603330149000_7.7.e017248.5","first-page":"Cd010236","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"10","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121603330149000_7.7.e017248.6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/11317640-000000000-00000","article-title":"Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies","volume":"33","author":"Banach","year":"2010","journal-title":"Drug Saf"},{"key":"2025121603330149000_7.7.e017248.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70323-X"},{"key":"2025121603330149000_7.7.e017248.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2270"},{"key":"2025121603330149000_7.7.e017248.9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/ajmg.a.35438","article-title":"Antiepileptic drugs and pregnancy outcomes","volume":"158A","author":"Wlodarczyk","year":"2012","journal-title":"Am J Med Genet A"},{"key":"2025121603330149000_7.7.e017248.10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40264-015-0269-9","article-title":"Neurodevelopmental effects of fetal antiepileptic drug exposure","volume":"38","author":"Velez-Ruiz","year":"2015","journal-title":"Drug Saf"},{"key":"2025121603330149000_7.7.e017248.11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/2046-4053-3-68","article-title":"Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis","volume":"3","author":"Tricco","year":"2014","journal-title":"Syst Rev"},{"key":"2025121603330149000_7.7.e017248.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.01.004"},{"key":"2025121603330149000_7.7.e017248.13","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2025121603330149000_7.7.e017248.14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med"},{"key":"2025121603330149000_7.7.e017248.15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 Guideline\u00a0Statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025121603330149000_7.7.e017248.16","unstructured":"Wells G , Shea B , O'Connell D , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2025121603330149000_7.7.e017248.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"2025121603330149000_7.7.e017248.18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.72"},{"key":"2025121603330149000_7.7.e017248.19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1875"},{"key":"2025121603330149000_7.7.e017248.20","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-159"},{"key":"2025121603330149000_7.7.e017248.21","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1045"},{"key":"2025121603330149000_7.7.e017248.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7387.472"},{"key":"2025121603330149000_7.7.e017248.23","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys222"},{"key":"2025121603330149000_7.7.e017248.24","doi-asserted-by":"crossref","unstructured":"Welton NJ , Sutton AJ , Cooper N , et al . Evidence synthesis for decision making in healthcare. New York: Wiley, 2012.","DOI":"10.1002\/9781119942986"},{"key":"2025121603330149000_7.7.e017248.25","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00353"},{"key":"2025121603330149000_7.7.e017248.26","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3680"},{"key":"2025121603330149000_7.7.e017248.27","unstructured":"Palmer T , Sterne J . White I , ed. Meta-Analysis in Stata: An Updated Collection from the Stata Journal. Texas: Stata Press, 2016."},{"key":"2025121603330149000_7.7.e017248.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d549"},{"key":"2025121603330149000_7.7.e017248.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2008.00552.x"},{"key":"2025121603330149000_7.7.e017248.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2025121603330149000_7.7.e017248.31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/M15-2521","article-title":"Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials","volume":"164","author":"Trinquart","year":"2016","journal-title":"Ann Intern Med"},{"key":"2025121603330149000_7.7.e017248.32","unstructured":"Bromley R , Baxter N , Calderbank R , et al . A comprehensive review of the language abilities of children exposed to valproate or carbamazepine in utero. Texas: American Epilepsy Society, 2010."},{"issue":"Suppl 2","key":"2025121603330149000_7.7.e017248.33","doi-asserted-by":"crossref","first-page":"A526.3","DOI":"10.1136\/archdischild-2014-307384.1466","article-title":"PO-0834\u2005Long-term Developmental Outcome Of Children Prenatally Exposed To Antiepileptic Drugs","volume":"99","author":"Gogatishvili","year":"2014","journal-title":"Arch Dis Child"},{"key":"2025121603330149000_7.7.e017248.34","unstructured":"Gogatishvili N , Ediberidze T , Lomidze G , et al . Cognitive outcomes of children with fetal antiepileptic drug exposure at the age of 3-6 years-preliminary data. 1st\u00a0624\u00a0Congress of the European Academy of Neurology. Berlin: European Journal of Neurology, 2015:p.329."},{"key":"2025121603330149000_7.7.e017248.35","doi-asserted-by":"crossref","unstructured":"Miskov S , Juraski RG , Fucic A , et al . Croatian pregnant women with Epilepsy and effects of antiepileptic drugs exposure in their offspring - seven years of prospective surveillance. Texas: American Epilepsy Society, 2010.","DOI":"10.1016\/S0022-510X(09)70974-8"},{"key":"2025121603330149000_7.7.e017248.36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.029132"},{"key":"2025121603330149000_7.7.e017248.37","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.4.251"},{"key":"2025121603330149000_7.7.e017248.38","unstructured":"Gaily E . Development and growth in children of epileptic mothers: a prospective controlled study. Helsinki, Finland: University of Helsinki, 1990."},{"key":"2025121603330149000_7.7.e017248.39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/ebeh.2001.0158","article-title":"Current Management of Epilepsy and Pregnancy: Fetal Outcome, Congenital Malformations, and Developmental Delay","volume":"2","author":"Katz","year":"2001","journal-title":"Epilepsy Behav"},{"key":"2025121603330149000_7.7.e017248.40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jclinepi.2016.02.016","article-title":"The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes","volume":"76","author":"Veroniki","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025121603330149000_7.7.e017248.41","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2013.4290","article-title":"Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy","volume":"70","author":"Veiby","year":"2013","journal-title":"JAMA Neurol"},{"key":"2025121603330149000_7.7.e017248.42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182088297"},{"key":"2025121603330149000_7.7.e017248.43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00228-017-2245-z","article-title":"Tolerability of new antiepileptic drugs: a network meta-analysis","volume":"73","author":"Zaccara","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2025121603330149000_7.7.e017248.44","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Green S , eds. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2009.","DOI":"10.1002\/9780470712184"},{"key":"2025121603330149000_7.7.e017248.45","first-page":"451","article-title":"Bias in identification of the best treatment in a Bayesian network meta-analysis for binary outcome: a simulation study","volume":"6","author":"Kibret","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2025121603330149000_7.7.e017248.46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198502283120906","article-title":"Seizure Disorders and Pregnancy","volume":"312","author":"Dalessio","year":"1985","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025121603330149000_7.7.e017248.47","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/sim.7223","article-title":"Combining randomized and non-randomized evidence in network meta-analysis","volume":"36","author":"Efthimiou","year":"2017","journal-title":"Stat Med"},{"key":"2025121603330149000_7.7.e017248.48","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/sim.5764","article-title":"Incorporating data from various trial designs into a mixed treatment comparison model","volume":"32","author":"Schmitz","year":"2013","journal-title":"Stat Med"},{"key":"2025121603330149000_7.7.e017248.49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13643-015-0133-0","article-title":"Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities","volume":"4","author":"Cameron","year":"2015","journal-title":"Syst Rev"},{"key":"2025121603330149000_7.7.e017248.50","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90201-Y"},{"key":"2025121603330149000_7.7.e017248.51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12874-016-0146-y","article-title":"A scoping review of indirect comparison methods and applications using individual patient data","volume":"16","author":"Veroniki","year":"2016","journal-title":"BMC Med Res Methodol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-017248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:33:14Z","timestamp":1765884794000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-017248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,20]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bmjopen-2017-017248"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-017248","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}